Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
1,202,864
-
Share change
-
+368,789
-
Total reported value
-
$5,489,000
-
Price per share
-
$4.56
-
Number of holders
-
14
-
Value change
-
+$1,081,290
-
Number of buys
-
8
-
Number of sells
-
12
Institutional Holders of Innate Pharma SA - SPONSORED ADS (IPHA) as of Q4 2021
As of 31 Dec 2021 Innate Pharma SA - SPONSORED ADS (IPHA) had 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,202,864 shares of stock of the company.
Largest 10 holders included BlackRock Inc., BANK OF AMERICA CORP /DE/, SILVERARC CAPITAL MANAGEMENT, LLC, ALPS ADVISORS INC, PURA VIDA INVESTMENTS, LLC, TWO SIGMA INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, JANE STREET GROUP, LLC, and TWO SIGMA ADVISERS, LP.
This table shows 14 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.